Hepion Pharmaceuticals Correlations

HEPA Stock  USD 0.58  0.02  3.33%   
The current 90-days correlation between Hepion Pharmaceuticals and Cytokinetics is 0.18 (i.e., Average diversification). The correlation of Hepion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Hepion Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Hepion Pharmaceuticals and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.

Moving together with Hepion Stock

  0.67ME 23Andme HoldingPairCorr
  0.67VANI Vivani MedicalPairCorr
  0.66VCEL Vericel Corp OrdPairCorr
  0.65VCNX VaccinexPairCorr
  0.71VERV Verve TherapeuticsPairCorr
  0.63DTIL Precision BioSciencesPairCorr
  0.63VIGL Vigil NeurosciencePairCorr
  0.75VIRI Virios Therapeutics Llc Symbol ChangePairCorr
  0.72VNDA Vanda PharmaceuticalsPairCorr
  0.64VRCA Verrica PharmaceuticalsPairCorr
  0.64VRPX Virpax PharmaceuticalsPairCorr
  0.66CDTTW Conduit PharmaceuticalsPairCorr
  0.61VRTX Vertex PharmaceuticalsPairCorr

Moving against Hepion Stock

  0.55VCYT VeracytePairCorr
  0.53A Agilent Technologies Fiscal Year End 18th of November 2024 PairCorr
  0.43DMAC DiaMedica TherapeuticsPairCorr
  0.4VERA Vera TherapeuticsPairCorr
  0.34DNLI Denali TherapeuticsPairCorr
  0.48VRDN Viridian Therapeutics Buyout TrendPairCorr
  0.48VRNA Verona Pharma PLCPairCorr
  0.32KTTAW Pasithea TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PMVPCYTK
RVMDEWTX
IPSCPMVP
IPSCSTTK
IPSCCSBR
DYNCYTK
  
High negative correlations   
STTKEWTX
DYNEWTX
THRDDYN
EWTXCYTK
ELYMEWTX
ELYMRVMD

Risk-Adjusted Indicators

There is a big difference between Hepion Stock performing well and Hepion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hepion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CYTK  1.65 (0.18) 0.00 (0.02) 0.00 
 3.35 
 9.84 
EWTX  4.04  0.48  0.16  0.28  3.59 
 7.17 
 61.02 
DYN  2.79 (0.44) 0.00 (0.10) 0.00 
 5.27 
 35.97 
THRD  2.67 (0.10)(0.02) 0.04  3.11 
 5.88 
 20.43 
PMVP  1.75 (0.17) 0.00 (0.05) 0.00 
 3.47 
 10.64 
RVMD  1.83  0.12  0.06  0.20  1.98 
 4.15 
 10.95 
STTK  4.98 (1.44) 0.00 (0.25) 0.00 
 9.00 
 54.53 
ELYM  4.08 (0.25) 0.00  1.60  0.00 
 9.09 
 34.87 
CSBR  2.89 (0.20) 0.00 (0.06) 0.00 
 5.76 
 21.23 
IPSC  4.60 (1.02) 0.00 (0.15) 0.00 
 11.51 
 30.97 

Hepion Pharmaceuticals Corporate Management

BSc BScCEO PresProfile
Patrick MayoSenior PharmacologyProfile
John CavanChief OfficerProfile
Sharen PyatetskayaDirector RelationsProfile
Todd MDChief OfficerProfile
Daniel TrepanierSenior DevelopmentProfile
Daren UreChief OfficerProfile